REPL - Replimune Group - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

REPL is currently covered by 6 analysts with an average price target of $12.3. This is a potential downside of $6.77 (-35.5%) from yesterday's end of day stock price of $19.07.

Replimune Group's activity chart (see below) currently has 137 price targets and 124 ratings on display. The stock rating distribution of REPL is 53.33% BUY, 40% HOLD and 6.67% SELL.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 51.58% of the time, taking 246.55 days on average.

Highest price target for REPL is $27, Lowest price target is $2, average price target is $12.3.

Most recent stock forecast was given by ALLISON BRATZEL from PIPER SANDLER. First documented stock forecast 14-Aug-2018.

Currently out of the existing stock ratings of REPL, 8 are a BUY (53.33%), 6 are a HOLD (40%), 1 are a SELL (6.67%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 04-Feb-2026

$27

$7.93 (41.58%)

$14

5 days ago
(15-Nov-2026)

Buy Since 07-Aug-2026

$21

$1.93 (10.12%)

$20

2 months 26 days ago
(26-Aug-2026)

16/18 (88.89%)

$5.12 (32.24%)

457

Hold Since 07-Aug-2026

$19

$-0.07 (-0.37%)

3 months 14 days ago
(07-Aug-2026)

10/15 (66.67%)

$6.94 (57.55%)

350

Hold Since 13-Apr-2026

$17

$-2.07 (-10.85%)

3 months 17 days ago
(04-Aug-2026)

5/11 (45.45%)

$5.08 (42.62%)

287

Buy Since 02-Nov-2020

$2

$-9.63 (-82.80%)

$8

7 months 8 days ago
(13-Apr-2026)

2/4 (50%)

$-2.76 (-57.98%)

36

Show more analysts

Please expand the browser size to see the chart

What is REPL (Replimune Group) average time for price targets to be met?

On average it took 247 days for the stock forecasts to be reached, with an average price target met ratio of 51.58%.

Which analyst most recently updated their price target on REPL (Replimune Group)?

Allison Bratzel

Which analyst has the most public recommendations on REPL (Replimune Group)?

Allison Bratzel works at PIPER SANDLER and has 4 price targets and 3 ratings on REPL

Which analyst is the currently most bullish on REPL (Replimune Group)?

Tony Butler with the highest potential upside of $40.93

Which analyst is the currently most reserved on REPL (Replimune Group)?

Roger Song with the lowest potential downside of -$17.07
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?